Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases

被引:3
|
作者
Zhu, Mengqi [1 ]
Huang, Yuting [2 ]
Bian, Saiyan [1 ]
Song, Qianqian [3 ]
Zhang, Jie [1 ]
Zheng, Wenjie [1 ]
Cheng, Chun [2 ]
机构
[1] Nantong Univ, Res Ctr Clin Med, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Med Sch, 19 Qixiu Rd, Nantong 226001, Peoples R China
[3] Wake Forest Sch Med, Dept Radiol, One Med Ctr Blvd, Winston Salem, NC 27157 USA
关键词
Liver organoids; pharmaceutical model; three-dimensional culture; liver diseases; epidermal growth factor; stem cells; HEPATIC STELLATE CELLS; STEM-CELLS; IN-VITRO; SELF-ORGANIZATION; CULTURE; MOUSE; BUILD; ACT; ORGANOGENESIS; REGENERATION;
D O I
10.2174/1874467213666201217115854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Understanding organogenesis, disorders, and repairing processes is particularly important for understanding the disease occurrence and developing treatment approaches. At present, liver-related studies are mainly conducted using in vivo models and cell lines, making it difficult to generalize the full picture of the structural characteristics and functions of human organs. Organoid is a three-dimensional (3D) culture system in vitro, which holds the promise to establish various disease models and conduct in-depth research by generating organ-like tissues in a dish. Recent advances in human liver organoids have provided a deeper understanding of this complex organ. In this review, we provide a systematic overview of the construction methods of organoids, focusing on their applications in the hepatic organogenesis and various liver disease models, as well as the limitations of current models. The development of organoid models is proving to be crucial in future liver research.
引用
收藏
页码:498 / 508
页数:11
相关论文
共 50 条
  • [41] Current Status in the Therapy of Liver Diseases
    Uhl, Philipp
    Fricker, Gert
    Haberkorn, Uwe
    Mier, Walter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (05): : 7500 - 7512
  • [42] Current applications of nanoparticles in infectious diseases
    Zazo, Hinojal
    Colino, Clara I.
    Lanao, Jose M.
    JOURNAL OF CONTROLLED RELEASE, 2016, 224 : 86 - 102
  • [43] Advances, challenges and future applications of liver organoids in experimental regenerative medicine
    Gong, Da
    Mo, Jiaye
    Zhai, Mei
    Zhou, Fulin
    Wang, Guocai
    Ma, Shaohua
    Dai, Xiaoyong
    Deng, Xuesong
    FRONTIERS IN MEDICINE, 2025, 11
  • [44] Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
    Shiota, Junya
    Samuelson, Linda C.
    Razumilava, Nataliya
    HEPATOLOGY, 2021, 74 (04) : 2251 - 2263
  • [45] Liver organoids: From 3D printing to biomedical applications
    Shi, Ying
    Han, Xin
    Zhang, Zheng
    Xu, Jiangtao
    Liu, Guozhen
    BMEMAT, 2024,
  • [46] Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications
    Cotovio, Joao P.
    Fernandes, Tiago G.
    BIOENGINEERING-BASEL, 2020, 7 (02):
  • [47] Molecular mechanisms of autophagy and implications in liver diseases
    Wu, Yuankai
    Tan, Hayden Weng Siong
    Lin, Jin-Yi
    Shen, Han-Ming
    Wang, Haihe
    Lu, Guang
    LIVER RESEARCH, 2023, 7 (01) : 56 - 70
  • [48] Gut mycobiome alterations and implications for liver diseases
    Zeng, Suling
    Schnabl, Bernd
    PLOS PATHOGENS, 2024, 20 (08)
  • [49] Current trends in liver biopsy indications in chronic liver diseases
    Cadranel, Jean-Francois
    Nousbaum, Jean-Baptiste
    PRESSE MEDICALE, 2012, 41 (11): : 1064 - 1070
  • [50] Implications of gut microbiota in autoimmune liver diseases
    Qian, Qiwei
    He, Wei
    Tang, Ruqi
    Ma, Xiong
    MINERVA GASTROENTEROLOGY, 2023, 69 (01): : 95 - 106